A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma

Condition:   Head and Neck Cancer
Interventions:   Drug: Pembrolizumab;   Radiation: Radiation Therapy;   Drug: Cisplatin
Sponsors:   Nooshin Hashemi-Sadraei;   Merck Sharp & Dohme Corp.
Recruiting - verified April 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/1TIrsxs
via IFTTT